A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

John A Radford; Catherine Thieblemont; Pier Luigi Zinzani

A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

John A Radford, Catherine Thieblemont, Pier Luigi Zinzani

APHP Hôpital Saint-Louis

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Blood
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0f5238034ec249b88a1ba2a6b02546a9,

title = "A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)",

author = "Radford, {John A} and Catherine Thieblemont and Zinzani, {Pier Luigi}",

year = "2014",

language = "Undefined",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

AU - Radford, John A

AU - Thieblemont, Catherine

AU - Zinzani, Pier Luigi

PY - 2014

Y1 - 2014

UR - https://publons.com/publon/9150949/

M3 - Article

SN - 0006-4971

JO - Blood

JF - Blood

ER -

A Phase II Open- Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

UN SDGs

Other files and links

Cite this